A cancer charity has said it is "angry and frustrated" that ministers and health officials have not approved the provision of ...

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Community leaders are coming together to support colorectal and prostate cancer awareness with a little friendly competition.

While prostate cancer statistics may seem daunting, advances in detection, treatment, and active surveillance offer patients ...

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.

U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that ...

Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...

Metastatic prostate cancer patients in the Capital Region now have a new treatment option at Ochsner MD Anderson Cancer ...

The retired NBA pro, who was diagnosed with kidney cancer at age 41, wants to give hope to others undergoing health challenges.

Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.

Scott Eggener, MD, gave a talk at the LUGPA annual meeting titled “Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments.” ...

Prostate cancer was the second leading cause of cancer deaths in North Carolina men in 2021; the bill aims to lower those rates.